REG-Qube Research & Technologies LTD Form 8.3 - Dalata Hotel Group PLC

Dalata HotelAnnouncement

Yesterday 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250718:nBw4hV5Pqa&default-theme=true


Form 8.3 - Dalata Hotel Group PLC

 

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH
TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE

1. KEY INFORMATION
 (a) Full name of discloser                                                       Qube Research & Technologies Limited      
 (b) Owner or controller of interests and short positions disclosed, if                                                     
 different from 1(a)                                                                                                        
 
                                                                                                                          
 
The naming of nominee or vehicle companies is insufficient. For a trust, the                                              
 trustee(s), settlor and beneficiaries must be named.                                                                       
 (c) Name of offeror/offeree in relation to whose relevant securities this form   Dalata Hotel Group plc                    
 relates                                                                                                                    
 
                                                                                                                          
 
Use a separate form for each offeror/offeree                                                                              
 (d) If an exempt fund manager connected with an offeror/offeree, state this                                                
 and specify identity of offeror/offeree (Note 1)                                                                           
 (e) Date position held/dealing undertaken                                        17-07-2025                                
 
                                                                                                                          
 
For an opening position disclosure, state the latest practicable date prior to                                            
 the disclosure                                                                                                             
 (f) In addition to the company in 1(c) above, is the discloser also making       N/A                                       
 disclosures in respect of any other party to the offer?                          
                                         
 
                                                                                
                                         
 
If it is a cash offer or possible cash offer, state “N/A”                                                                 


2. INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class
of relevant securities of the offeror or offeree named in 1(c), copy table 2
for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)

(Note 2)
 Class of relevant security                                                     €0.01 ordinary shares                  
 
(Note 3)                                                                                                             
                                                                                Interests          Short positions     
                                                                                Number     %       Number    %         
 (1) Relevant securities owned and/or controlled                                0          0       0         0         
 (2) Cash-settled derivatives                                                   2,147,914  1.01    0         0         
 (3) Stock-settled derivatives (including options) and agreements to purchase/  0          0       0         0         
 sell                                                                                                                  
 Total                                                                          2,147,914  1.01    0         0         


All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any
open stock-settled derivative positions (including traded options), or
agreements to purchase or sell relevant securities, should be given on a
Supplemental Form 8.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales
 Class of relevant   Purchase/sale  Number of    Price per unit   
 
security                          
securities  
(Note 5)        
                                                                  
                                                 
                
                                                 
                


Ap29

(b) Cash-settled derivative transactions
 Class of                 Product        Nature of dealing                                                            Number of     Price       
 
relevant                
description   
e.g. opening/ closing a long/ short position, increasing/ reducing a long/  
reference    
per unit   
 
security                
e.g. CFD      short position                                                               
securities   
(Note 5)   
                                                                                                                      
(Note 6)                 
 €0.01 ordinary shares    Equity Swap    Increasing a long position                                                   41,454        6.39        
 €0.01 ordinary shares    Equity Swap    Increasing a long position                                                   5,099         6.38        
 €0.01 ordinary shares    Equity Swap    Increasing a long position                                                   2             6.40        
 €0.01 ordinary shares    Equity Swap    Decreasing a long position                                                   4,947         6.39        
 €0.01 ordinary shares    Equity Swap    Decreasing a long position                                                   4             6.40        


(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying
 Class of    Product                  Writing, purchasing, selling, varying   Number        Exercise     Type         Expiry   Option              
 
relevant   
description e.g. call   
etc.                                   
of           
price per   
e.g.        
date    
money              
 
security   
option                                                          
securities   
unit        
American,            
paid/              
                                                                              
to which                  
European             
received per unit  
                                                                              
option                    
etc.                                     
                                                                              
relates                                                             
                                                                              
(Note 6)                                                            
                                                                                                                                                   


(ii) Exercise
 Class of    Product        Exercising/   Number of    Exercise     
 
relevant   
description   
exercised    
securities  
price per   
 
security   
e.g. call     
against                   
unit        
             
option                                   
(Note 5)    
                                                                    


(d) Other dealings (including transactions in respect of new securities) (Note
3)
 Class of    Nature of dealing      Details  Price per unit (if   
 
relevant   
e.g. subscription,             
applicable)         
 
security   
conversion, exercise           
(Note 5)            
                                                                  
                                             
                    
                                             
                    


Ap30

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements
 Details of any indemnity or option arrangement, or any agreement or              
 understanding, formal or informal, relating to relevant securities which may     
 be an inducement to deal or refrain from dealing entered into by the person      
 making the disclosure and any party to the offer or any person acting in         
 concert with a party to the offer.                                               
 
                                                                                
 
Irrevocable commitments and letters of intent should not be included. If there  
 are no such agreements, arrangements or understandings, state “none”             
 None                                                                             


(b) Agreements, arrangements or understandings relating to options or
derivatives
 Full details of any agreement, arrangement or understanding between the person   
 disclosing and any other person relating to the voting rights of any relevant    
 securities under any option referred to on this form or relating to the voting   
 rights or future acquisition or disposal of any relevant securities to which     
 any derivative referred to on this form is referenced. If none, this should be   
 stated.                                                                          
 None                                                                             


(c) Attachments
 Is a Supplemental Form 8 attached?  NO  

 Date of disclosure  18-07-2025      
 Contact name        Janice Falcao   
 Telephone number    00442033140679  


Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory
Information Service.



View source version on businesswire.com:
https://www.businesswire.com/news/home/20250718645044/en/
(https://www.businesswire.com/news/home/20250718645044/en/)

Qube Research & Technologies LTD


Copyright Business Wire 2025